Biotechnology:

Business Communications Company Inc.
Management Report  October 2005


Table of Contents

INTRODUCTION

The prosthetics, orthotics and cosmetic enhancement products industries are entering into a period of extraordinary opportunities. This is due to a convergence of technological, demographic, cultural and economic factors. Advances in materials technology, miniaturization, electronics and operative procedures are opening up many new possibilities.

At the same time, the populations of the U.S. and other advanced countries are growing older, resulting in a continual growth in the number of people suffering from physical disabilities and other conditions that medical science increasingly is equipped to ameliorate. Many of these same individuals have enjoyed unprecedented earnings during their working lives, and look forward to financially comfortable retirement years. As a result, they will have the money to spend on prosthetics, orthotics and cosmetic enhancement products, with or without the help of health insurance.

This BCC report is both a survey of products on the marketplace and a preview of things to come. The study examines market opportunities for prosthetic and orthotics devices and cosmetic enhancement products and the technologies that make possible the more advanced products that rapidly are coming into being.

SCOPE OF STUDY

The report contains:

• Discussion of major product types and applications, both commercial and developmental
• An overview of market size and segmentation, including historical data on sales by application and product type
• Market drivers and constraints
• Detailed market projections through 2010
• Analysis of industry structure, competition and market shares
• Discussion of factors that may influence the long-term market for prosthetic and orthotics devices and cosmetic enhancement products.

REPORT HIGHLIGHTS

The U.S. market for prosthetics, orthotics and cosmetic enhancement products is expected to increase from $6.8 billion in 2005 to $10.8 billion in 2010, at an AAGR (average annual growth rate) of 9.9%.

Cosmetic enhancement products have a much higher projected AAGR (28.2%) than either prosthetics (5.5%) or orthotics (3.6%). As a result, cosmetic enhancement products will increase their market share to 30.3% in 2010.

Both prostheses and orthoses are expected to lose market share, i.e., from 78.9% to 63.3% and from 8.8% to 6.4%, respectively.

Currently, the largest-selling products are dental crowns and bridges and hip and knee implants. Products expected to show the greatest growth by 2010 include botulinum toxin dermal fillers and dental implants.

For full details, please email jenniferc@cmsinfo.com

Order Form

For more information about us, visit CMSinfo.